214 related articles for article (PubMed ID: 2378463)
21. Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.
Deringer JR; Chen C; Samuel JE; Brown WC
Microbiology (Reading); 2011 Feb; 157(Pt 2):526-542. PubMed ID: 21030434
[TBL] [Abstract][Full Text] [Related]
22. [The phase variation of Coxiella burnetii (theory and practice)].
Pautov VN
Zh Mikrobiol Epidemiol Immunobiol; 1989 Sep; (9):97-103. PubMed ID: 2686315
[No Abstract] [Full Text] [Related]
23. Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray.
Beare PA; Chen C; Bouman T; Pablo J; Unal B; Cockrell DC; Brown WC; Barbian KD; Porcella SF; Samuel JE; Felgner PL; Heinzen RA
Clin Vaccine Immunol; 2008 Dec; 15(12):1771-9. PubMed ID: 18845831
[TBL] [Abstract][Full Text] [Related]
24. Antigenicity of chloroform-methanol-treated Coxiella burnetii preparations.
Kazár J; Schramek S; Lisák V; Brezina R
Acta Virol; 1987 Mar; 31(2):158-67. PubMed ID: 2886025
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice.
Zhang G; Russell-Lodrigue KE; Andoh M; Zhang Y; Hendrix LR; Samuel JE
J Immunol; 2007 Dec; 179(12):8372-80. PubMed ID: 18056383
[TBL] [Abstract][Full Text] [Related]
26. Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model.
Moos A; Hackstadt T
Infect Immun; 1987 May; 55(5):1144-50. PubMed ID: 3570458
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens.
Izzo AA; Marmion BP; Hackstadt T
Clin Exp Immunol; 1991 Jul; 85(1):98-108. PubMed ID: 2070564
[TBL] [Abstract][Full Text] [Related]
28. Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.
Zhang YX; Zhi N; Yu SR; Li QJ; Yu GQ; Zhang X
Acta Virol; 1994 Dec; 38(6):327-32. PubMed ID: 7793356
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of
Sluder AE; Raju Paul S; Moise L; Dold C; Richard G; Silva-Reyes L; Baeten LA; Scholzen A; Reeves PM; Pollard AJ; Garritsen A; Bowen RA; De Groot AS; Rollier C; Poznansky MC
Front Immunol; 2022; 13():901372. PubMed ID: 35651616
[TBL] [Abstract][Full Text] [Related]
30. Identification and cloning of a 27-kDa Coxiella burnetii immunoreactive protein.
Hendrix LR; Samuel JE; Mallavia LP
Ann N Y Acad Sci; 1990; 590():534-40. PubMed ID: 2378476
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of Coxiella burnetii whole cells and their outer membrane components.
Gajdosová E; Kovácová E; Toman R; Skultéty L; Lukácová M; Kazár J
Acta Virol; 1994 Dec; 38(6):339-44. PubMed ID: 7793358
[TBL] [Abstract][Full Text] [Related]
32. Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.
Gong W; Wang P; Xiong X; Jiao J; Yang X; Wen B
PLoS One; 2015; 10(4):e0124664. PubMed ID: 25909586
[TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of an up-converting phosphor technology-based lateral flow assay for rapid and quantitative detection of Coxiella burnetii phase I strains.
Zhang P; Jiao J; Zhao Y; Fu M; Wang J; Song Y; Zhou D; Wang Y; Wen B; Yang R; Xiong X
BMC Microbiol; 2020 Aug; 20(1):251. PubMed ID: 32787788
[TBL] [Abstract][Full Text] [Related]
34. Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses.
Chen C; Dow C; Wang P; Sidney J; Read A; Harmsen A; Samuel JE; Peters B
PLoS One; 2011 Mar; 6(3):e17712. PubMed ID: 21423609
[TBL] [Abstract][Full Text] [Related]
35. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
Williams JC; Peacock MG; Waag DM; Kent G; England MJ; Nelson G; Stephenson EH
Ann N Y Acad Sci; 1992 Jun; 653():88-111. PubMed ID: 1626897
[TBL] [Abstract][Full Text] [Related]
36. Coxiella burnetii antigens for detection of Q fever antibodies by ELISA in human sera.
Kovácová E; Gallo J; Schramek S; Kazár J; Brezina R
Acta Virol; 1987 May; 31(3):254-9. PubMed ID: 2888290
[TBL] [Abstract][Full Text] [Related]
37. The Feasibility of Using
Kumaresan V; Alam S; Zhang Y; Zhang G
Front Immunol; 2021; 12():754690. PubMed ID: 34795669
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity and protective ability of corpuscular and soluble vaccines prepared from different Coxiella burnetii phase I strains.
Kazár J; Gajdosová E; Kovácová E; Valková D
Acta Virol; 1995 Dec; 39(5-6):243-9. PubMed ID: 8722292
[TBL] [Abstract][Full Text] [Related]
39. Exploratory study on Th1 epitope-induced protective immunity against Coxiella burnetii infection.
Xiong X; Qi Y; Jiao J; Gong W; Duan C; Wen B
PLoS One; 2014; 9(1):e87206. PubMed ID: 24498044
[TBL] [Abstract][Full Text] [Related]
40. Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host--implications for post Q fever infection fatigue syndrome and other chronic sequelae.
Marmion BP; Sukocheva O; Storm PA; Lockhart M; Turra M; Kok T; Ayres J; Routledge H; Graves S
QJM; 2009 Oct; 102(10):673-84. PubMed ID: 19556396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
